Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Ocaña, A.
Right arrow Articles by Stewart, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Ocaña, A.
Right arrow Articles by Stewart, A. F.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:2752-2762, 2001
© 2001 by the American Diabetes Association, Inc.

Transgenic Overexpression of Hepatocyte Growth Factor in the ß-Cell Markedly Improves Islet Function and Islet Transplant Outcomes in Mice

Adolfo García-Ocaña, Rupangi C. Vasavada, Ana Cebrian, Vasumathi Reddy, Karen K. Takane, Juan-Carlos López-Talavera, and Andrew F. Stewart

Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Recent advances in human islet transplantation have highlighted the need for expanding the pool of ß-cells available for transplantation. We have developed three transgenic models in which growth factors (hepatocyte growth factor [HGF], placental lactogen, or parathyroid hormone-related protein) have been targeted to the ß-cell using rat insulin promoter (RIP). Each displays an increase in islet size and islet number, and each displays insulin-mediated hypoglycemia. Of these three models, the RIP-HGF mouse displays the least impressive phenotype under basal conditions. In this study, we show that this mild basal phenotype is misleading and that RIP-HGF mice have a unique and salutary phenotype. Compared with normal islets, RIP-HGF islets contain more insulin per ß-cell (50 ± 5 vs. 78 ± 9 ng/islet equivalent [IE] in normal vs. RIP-HGF islets, P < 0.025), secrete more insulin in response to glucose in vivo (0.66 ± 0.06 vs. 0.91 ± 0.10 ng/ml in normal vs. RIP-HGF mice, P < 0.05) and in vitro (at 22.2 mmol/l glucose: 640 ± 120.1 vs. 1,615 ± 196.9 pg · µg protein-1 · 30 min-1 in normal vs. RIP-HGF islets, P < 0.01), have two- to threefold higher GLUT2 and glucokinase steady-state mRNA levels, take up and metabolize glucose more effectively, and most importantly, function at least twice as effectively after transplantation. These findings indicate that HGF has surprisingly positive effects on ß-cell mitogenesis, glucose sensing, ß-cell markers of differentiation, and transplant survival. It appears to have a unique and unanticipated effective profile as an islet mass- and function-enhancing agent in vivo.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
N. M. Fiaschi-Taesch, D. M. Berman, B. M. Sicari, K. K. Takane, A. Garcia-Ocana, C. Ricordi, N. S. Kenyon, and A. F. Stewart
Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets
Diabetes, October 1, 2008; 57(10): 2745 - 2754.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. C. Vasavada, L. Wang, Y. Fujinaka, K. K. Takane, T. C. Rosa, J. M.D. Mellado-Gil, P. A. Friedman, and A. Garcia-Ocana
Protein Kinase C-{zeta} Activation Markedly Enhances {beta}-Cell Proliferation: An Essential Role in Growth Factor Mediated {beta}-Cell Mitogenesis
Diabetes, November 1, 2007; 56(11): 2732 - 2743.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. C. Alonso, T. Yokoe, P. Zhang, D. K. Scott, S. K. Kim, C. P. O'Donnell, and A. Garcia-Ocana
Glucose Infusion in Mice: A New Model to Induce {beta}-Cell Replication
Diabetes, July 1, 2007; 56(7): 1792 - 1801.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. C. Vasavada, I. Cozar-Castellano, D. Sipula, and A. F. Stewart
Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic {beta}-Cell Has Limited Effects on {beta}-Cell Replication, Mass, and Function
Diabetes, January 1, 2007; 56(1): 57 - 64.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Cozar-Castellano, M. Haught, and A. F. Stewart
The Cell Cycle Inhibitory Protein p21cip Is Not Essential for Maintaining {beta}-Cell Cycle Arrest or {beta}-Cell Function In Vivo
Diabetes, December 1, 2006; 55(12): 3271 - 3278.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart
Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell
Endocr. Rev., June 1, 2006; 27(4): 356 - 370.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Johansson, G. Mattsson, A. Andersson, L. Jansson, and P.-O. Carlsson
Islet Endothelial Cells and Pancreatic {beta}-Cell Proliferation: Studies in Vitro and during Pregnancy in Adult Rats
Endocrinology, May 1, 2006; 147(5): 2315 - 2324.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Luo, S. M. Liu, H. Liu, Q. Li, Q. Xu, X. Sun, B. Davis, J. Li, and S. Chua Jr.
Allelic Variation on Chromosome 5 Controls {beta}-Cell Mass Expansion during Hyperglycemia in Leptin Receptor-Deficient Diabetes Mice
Endocrinology, May 1, 2006; 147(5): 2287 - 2295.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Cozar-Castellano, M. Weinstock, M. Haught, S. Velazquez-Garcia, D. Sipula, and A. F. Stewart
Evaluation of {beta}-Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental Lactogen: Comprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21cip
Diabetes, January 1, 2006; 55(1): 70 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Dai, C.-G. Huh, S. S. Thorgeirsson, and Y. Liu
{beta}-Cell-Specific Ablation of the Hepatocyte Growth Factor Receptor Results in Reduced Islet Size, Impaired Insulin Secretion, and Glucose Intolerance
Am. J. Pathol., August 1, 2005; 167(2): 429 - 436.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Roccisana, V. Reddy, R. C. Vasavada, J. A. Gonzalez-Pertusa, M. A. Magnuson, and A. Garcia-Ocana
Targeted Inactivation of Hepatocyte Growth Factor Receptor c-met in {beta}-Cells Leads to Defective Insulin Secretion and GLUT-2 Downregulation Without Alteration of {beta}-Cell Mass
Diabetes, July 1, 2005; 54(7): 2090 - 2102.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Rao, J. Roccisana, K. K. Takane, R. Bottino, A. Zhao, M. Trucco, and A. Garcia-Ocana
Gene Transfer of Constitutively Active Akt Markedly Improves Human Islet Transplant Outcomes in Diabetic Severe Combined Immunodeficient Mice
Diabetes, June 1, 2005; 54(6): 1664 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Fujikawa, S.-H. Oh, L. Pi, H. M. Hatch, T. Shupe, and B. E. Petersen
Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells
Am. J. Pathol., June 1, 2005; 166(6): 1781 - 1791.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Fujinaka, D. Sipula, A. Garcia-Ocana, and R. C. Vasavada
Characterization of Mice Doubly Transgenic for Parathyroid Hormone-Related Protein and Murine Placental Lactogen: A Novel Role for Placental Lactogen in Pancreatic {beta}-Cell Survival
Diabetes, December 1, 2004; 53(12): 3120 - 3130.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
R Wang, N Yashpal, F Bacchus, and J Li
Hepatocyte growth factor regulates proliferation and differentiation of epithelial monolayers derived from islets of postnatal rat pancreas
J. Endocrinol., October 1, 2004; 183(1): 163 - 171.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. M. Harlan
Gene-Altered Islets for Transplant: Giant Leap or Small Step?
Endocrinology, February 1, 2004; 145(2): 463 - 466.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
J. C. Lopez-Talavera, A. Garcia-Ocana, I. Sipula, K. K. Takane, I. Cozar-Castellano, and A. F. Stewart
Hepatocyte Growth Factor Gene Therapy for Pancreatic Islets in Diabetes: Reducing the Minimal Islet Transplant Mass Required in a Glucocorticoid-Free Rat Model of Allogeneic Portal Vein Islet Transplantation
Endocrinology, February 1, 2004; 145(2): 467 - 474.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Cozar-Castellano, K. K. Takane, R. Bottino, A.N. Balamurugan, and A. F. Stewart
Induction of {beta}-Cell Proliferation and Retinoblastoma Protein Phosphorylation in Rat and Human Islets Using Adenovirus-Mediated Transfer of Cyclin-Dependent Kinase-4 and Cyclin D1
Diabetes, January 1, 2004; 53(1): 149 - 159.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Farilla, A. Bulotta, B. Hirshberg, S. Li Calzi, N. Khoury, H. Noushmehr, C. Bertolotto, U. Di Mario, D. M. Harlan, and R. Perfetti
Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human Islets
Endocrinology, December 1, 2003; 144(12): 5149 - 5158.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Dai, Y. Li, J. Yang, and Y. Liu
Hepatocyte Growth Factor Preserves Beta Cell Mass and Mitigates Hyperglycemia in Streptozotocin-induced Diabetic Mice
J. Biol. Chem., July 11, 2003; 278(29): 27080 - 27087.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Ricordi
Lilly Lecture 2002: Islet Transplantation: A Brave New World
Diabetes, July 1, 2003; 52(7): 1595 - 1603.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Suzuki, H. Nakauchi, and H. Taniguchi
Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells
PNAS, April 29, 2003; 100(9): 5034 - 5039.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Garcia-Ocana, K. K. Takane, V. T. Reddy, J.-C. Lopez-Talavera, R. C. Vasavada, and A. F. Stewart
Adenovirus-mediated Hepatocyte Growth Factor Expression in Mouse Islets Improves Pancreatic Islet Transplant Performance and Reduces Beta Cell Death
J. Biol. Chem., January 3, 2003; 278(1): 343 - 351.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Cebrian, A. Garcia-Ocana, K. K. Takane, D. Sipula, A. F. Stewart, and R. C. Vasavada
Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic {beta}-Cell Death In Vivo and In Vitro
Diabetes, October 1, 2002; 51(10): 3003 - 3013.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.